Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;100(8):e1541-e1552.
doi: 10.1111/aos.15191. Epub 2022 Jun 13.

What did we learn in 35 years of research on nutrition and supplements for age-related macular degeneration: a systematic review

Affiliations

What did we learn in 35 years of research on nutrition and supplements for age-related macular degeneration: a systematic review

Els M Pameijer et al. Acta Ophthalmol. 2022 Dec.

Abstract

The aim of this paper is to summarize all available evidence from systematic reviews, randomized controlled trials (RCTs) and comparative nonrandomized studies (NRS) on the association between nutrition and antioxidant, vitamin, and mineral supplements and the development or progression of age-related macular degeneration (AMD). The Cochrane Database of Systematic Reviews, Cochrane register CENTRAL, MEDLINE and Embase were searched and studies published between January 2015 and May 2021 were included. The certainty of evidence was assessed according to the GRADE methodology. The main outcome measures were development of AMD, progression of AMD, and side effects. We included 7 systematic reviews, 7 RCTs, and 13 NRS. A high consumption of specific nutrients, i.e. β-carotene, lutein and zeaxanthin, copper, folate, magnesium, vitamin A, niacin, vitamin B6, vitamin C, docosahexaenoic acid, and eicosapentaenoic acid, was associated with a lower risk of progression of early to late AMD (high certainty of evidence). Use of antioxidant supplements and adherence to a Mediterranean diet, characterized by a high consumption of vegetables, whole grains, and nuts and a low consumption of red meat, were associated with a decreased risk of progression of early to late AMD (moderate certainty of evidence). A high consumption of alcohol was associated with a higher risk of developing AMD (moderate certainty of evidence). Supplementary vitamin C, vitamin E, or β-carotene were not associated with the development of AMD, and supplementary omega-3 fatty acids were not associated with progression to late AMD (high certainty of evidence). Research in the last 35 years included in our overview supports that a high intake of specific nutrients, the use of antioxidant supplements and adherence to a Mediterranean diet decrease the risk of progression of early to late AMD.

Keywords: AMD; Cochrane; age-related macular degeneration; nutrition; supplements; systematic review.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Agrón E, Mares J, Clemons TE, Swaroop A, Chew EY & Keenan TDL (2021): Dietary nutrient intake and progression to late age‐related macular degeneration in the age‐related eye disease studies 1 and 2. Ophthalmology 128: 425–442. - PMC - PubMed
    1. Akuffo KO, Beatty S, Peto T et al. (2017): The impact of supplemental antioxidants on visual function in nonadvanced age‐related macular degeneration: A head‐to‐head randomized clinical trial. Investig Ophthalmol Vis Sci 58: 5347–5360. - PubMed
    1. Broadhead GK, Grigg JR, McCluskey P, Hong T, Schlub TE & Chang AA (2018): Saffron therapy for the treatment of mild/moderate age‐related macular degeneration: A randomised clinical trial. Graefes Arch Clin Exp Ophthalmol 257: 31–40. - PubMed
    1. Chapman NA, Jacobs RJ & Braakhuis AJ (2019): Role of diet and food intake in age‐related macular degeneration: A systematic review. Clin Exp Ophthalmol 47: 106–127. - PubMed
    1. Chew E, Clemons TE, SanGiovanni JP et al. (2013): Lutein + zeaxanthin and omega‐3 fatty acids for age‐related macular degeneration: The age‐related eye disease study 2 (AREDS2) randomized clinical trial. JAMA 309: 2005–2015. - PubMed

Publication types

MeSH terms

Grants and funding